Individual test method development
Novel materials, evolving designs, and ambitious performance targets often fall outside the boundaries of established standards when it comes to testing new medical devices. You are expected to demonstrate safety, prove performance, and satisfy global regulators, all while maintaining timelines that leave little room for delay. Without the right testing strategy, even the most promising innovation can face costly setbacks or prolonged approval pathways.
The Eurofins Medical Device Services (MDS) network of laboratories provides the expertise required to navigate this complexity. We work in close partnership with manufacturers to design and develop tailored test methods that reflect the specific characteristics of each device, ensuring robust, regulator-ready results.
Our approach begins with custom protocol design. Where standard ISO or ASTM methods are insufficient, we develop device-specific methodologies that accurately assess safety and performance under realistic conditions. This ensures your data is both relevant and defensible.
We integrate regulatory alignment at every stage. Our teams design methods that meet expectations from global authorities, including FDA, EMA, and MDR frameworks. This structured approach supports smoother submissions and reduces the risk of regulatory queries. Using advanced instrumentation and simulation environments, we can replicate physiological conditions to generate meaningful insights into device behaviour. These controlled environments allow us to evaluate performance in ways that closely mirror real-world use.
We also deliver full validation and documentation, with every method validated with complete traceability and supported by detailed reporting that strengthens your regulatory submission and audit readiness.
By combining scientific depth with regulatory understanding, we enable faster, more confident decision-making. With access to experienced scientists, cutting-edge facilities, and proven processes, Eurofins MDS will help you transform complex challenges into compliant, high-quality outcomes, ensuring your innovation reaches patients with precision.
Individual test method development that delivers
No two medical devices behave in exactly the same way. So when testing relies on standard equipment alone, critical nuances in performance can be overlooked. This can lead to gaps in understanding, delayed development, and challenges in demonstrating real-world reliability to regulators and stakeholders.
The Eurofins Medical Device Services (MDS) network of laboratories designs and builds individual test setups tailored to the unique characteristics of your device. We develop device-specific rigs that reflect intended use, combining mechanical, fluidic, and hybrid systems to replicate relevant loading and environmental conditions.
Our capabilities include physiologically accurate simulation of pressure, flow, motion, and temperature, alongside modular system architectures that support rapid iteration and comparative testing. Integrated instrumentation, automated control, and high-resolution data acquisition ensure precise, traceable results.
The customised environments Eurofins MDS develops enable realistic performance evaluation, reduce development risk, and generate clear, well-documented evidence. The result is a more confident path to optimisation, regulatory acceptance, and successful innovation.
Next-generation mock loops
As medical devices grow more sophisticated, conventional testing environments can struggle to keep pace. When physiological conditions are not accurately replicated, it becomes harder to predict real-world performance, refine designs, or build a strong case for regulatory approval. This gap can introduce uncertainty, slow development, and limit confidence in results.
The Eurofins Medical Device Services (MDS) network of laboratories develops next-generation mock loop systems engineered to mirror complex biological environments with high precision. We create custom physiological models, including cardiovascular and multi-system loops, designed to reflect realistic anatomical and haemodynamic conditions.
Our systems incorporate dynamic control of pressure, flow, and compliance, enabling simulation of both normal and pathological states. Using advanced materials and precision fabrication, we produce high-fidelity models supported by integrated sensors, imaging access, and automated data capture.
The Eurofins MDS approach delivers controlled, repeatable testing conditions that enhance clinical relevance, support design optimisation, and generate robust, well-documented evidence for regulatory submissions, helping you move forward with clarity and confidence.
In vitro validation
When simulation results are used to inform critical decisions, you need clear, measurable evidence that your model reflects real-world performance. Without robust validation, regulatory acceptance becomes more complex, development timelines extend, and confidence in outcomes decreases.
The Eurofins Medical Device Services (MDS) network of laboratories designs and delivers targeted in vitro validation studies aligned with ASME V&V 40. Our experts develop physiologically relevant test setups, including custom mock loops, anatomical models, and mechanical rigs that replicate real-use conditions.
Our approach ensures each validation protocol is tailored to the model’s intended use, supporting a risk-informed credibility framework. High-resolution measurement techniques capture flow, pressure, displacement, and strain, alongside advanced imaging such as PIV and high-speed analysis.
All data is generated within controlled, reproducible environments, with full traceability, uncertainty quantification, and transparent reporting. The in vitro validation studies Eurofins MDS conducts enables direct comparison between simulation and physical behaviour, strengthening regulatory submissions and supporting faster, more confident development decisions.